Veterinary Medicines

FILOLINC 400, 400 mg/g Polvere per soluzione orale per suini, broiler (escluso galline che producono uova destinate al consumo umano)

Authorised
  • Lincomycin
Download as PDF

Product identification

Medicine name:
FILOLINC 400, 400 mg/g Polvere per soluzione orale per suini, broiler (escluso galline che producono uova destinate al consumo umano)
FILOLINC 400, 400 mg/g Polvere per soluzione orale per suini, broiler (escluso galline che producono uova destinate al consumo umano)
Active substance:
  • Lincomycin
Target species:
  • Pig
  • Chicken (broiler)
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Lincomycin
    400.00
    milligram(s)
    /
    1.00
    gram(s)
Pharmaceutical form:
  • Powder for oral solution
Withdrawal period by route of administration:
  • Oral use
    • Pig
      • Meat and offal
        0
        day
    • Chicken (broiler)
      • Meat and offal
        5
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01FF02
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Italy
Available in:
  • Italy
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • HuVepharma
Marketing authorisation date:
Manufacturing sites for batch release:
  • Huvepharma
Responsible authority:
  • Ministry Of Health
Authorisation number:
  • 104734
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Italian (PDF)
Published on: 3/05/2023
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."